The Journal of Immunology, Vol 139, Issue 6 1818-1822, Copyright © 1987 by American Association of Immunologists

ARTICLES

Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells

N Feuerstein and JJ Mond

Experiments were undertaken to identify nuclear proteins that might be involved in regulation of the mitogenic process in B lymphocytes. Murine splenic B lymphocytes were purified and cultured with anti-Ig insolubilized onto Sepharose (anti-Ig/Sepharose) for 16 hr and labeled with [35S]methionine. Nuclei were isolated and the nuclear proteins were analyzed by two-dimensional gel electrophoresis. Anti-Ig/Sepharose induced a prominent increase in the synthesis and abundance of a 40 kDa/pI 5 nuclear protein (p40/pI-5). Inhibition of anti-Ig/Sepharose- induced mitogenesis by pretreatment of the cells with phorbol-12- myristate-13-acetate was associated with a specific inhibition (63%) of p40/pI-5. Subcellular fractionation experiments showed that p40/pI-5 is not detected in the soluble fraction of resting or activated B cells, indicating that this protein is located exclusively in the nucleus. Analysis of the expression of p40/pI-5 relative the cell cycle showed that the synthesis of this protein was increased during G1 phase and gradually reduced during S phase of the cell cycle. Abundant amounts of p40/pI-5 were also found in the rapidly proliferating B lymphoma cells, WEHI-231, and growth arrest of these cells by anti-mu was found to be associated with a marked inhibition (68%) of this protein. Taken collectively these results suggest that the nuclear protein p40/pI-5 may have an important role in regulation of the proliferation of normal and malignant B lymphocytes.

This article has been cited by other articles:

				J. Li, D. P. Sejas, R. Rani, T. Koretsky, G. C. Bagby, and Q. Pang Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem/Progenitor Cells J. Biol. Chem., June 16, 2006; 281(24): 16536 - 16545. [Abstract] [Full Text] [PDF]

				K. Gonda, J. Wudel, D. Nelson, N. Katoku-Kikyo, P. Reed, H. Tamada, and N. Kikyo Requirement of the Protein B23 for Nucleolar Disassembly Induced by the FRGY2a Family Proteins J. Biol. Chem., March 24, 2006; 281(12): 8153 - 8160. [Abstract] [Full Text] [PDF]

				J. Li, X. Zhang, D. P. Sejas, G. C. Bagby, and Q. Pang Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53 J. Biol. Chem., October 1, 2004; 279(40): 41275 - 41279. [Abstract] [Full Text] [PDF]

				Q. Pang, T. A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keeble, G. R. Faulkner, A. Speckhart, and G. C. Bagby Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR J. Biol. Chem., October 24, 2003; 278(43): 41709 - 41717. [Abstract] [Full Text] [PDF]

				K. I. Zeller, T. J. Haggerty, J. F. Barrett, Q. Guo, D. R. Wonsey, and C. V. Dang Characterization of Nucleophosmin (B23) as a Myc Target by Scanning Chromatin Immunoprecipitation J. Biol. Chem., December 14, 2001; 276(51): 48285 - 48291. [Abstract] [Full Text] [PDF]

				C. C. Chou and B. Y. M. Yung Increased Stability of Nucleophosmin/B23 in Anti-Apoptotic Effect of Ras during Serum Deprivation Mol. Pharmacol., January 1, 2001; 59(1): 38 - 45. [Abstract] [Full Text]

				S. D. Patterson, J. S. Grossman, P. D'Andrea, and G. I. Latter Reduced Numatrin/B23/Nucleophosmin Labeling in Apoptotic Jurkat T-lymphoblasts J. Biol. Chem., April 21, 1995; 270(16): 9429 - 9436. [Abstract] [Full Text] [PDF]

				K. Hingorani, A. Szebeni, and M. O. J. Olson Mapping the Functional Domains of Nucleolar Protein B23 J. Biol. Chem., August 4, 2000; 275(32): 24451 - 24457. [Abstract] [Full Text] [PDF]